Vision Loss Due to Elmiron?
Have you or someone you know taken the drug Elmiron and experienced any of these symptoms?
Multiple studies have now confirmed that the drug Elmiron is linked to a serious vision condition called pigmentary maculopathy. Elmiron, manufactured by Janssen Pharmaceuticals, is prescribed for the treatment of interstitial cystitis, a painful bladder condition. Janssen Pharmaceuticals is accused of failing to properly warn the public about the risk of vision problems. Recent studies linked the interstitial cystitis (IC) drug, also known as pentosan polysulfate sodium (PPS), to ocular toxicity and irreversible vision damage.
In 2018, an article was published by the American Academy of Ophthalmology in which the authors wrote about six patients treated at Emory Eye Center between 2015 and 2017 who experienced pigmentary maculopathy of unclear cause following chronic exposure to Elmiron (pentosan polysulfate sodium) for interstitial cystitis.
In 2019, one of the authors issued an update writing that ten patients at Emory Eye Center had been diagnosed with this same issue.
The form of macular degeneration that has been linked with Elmiron is identified as “pigmentary maculopathy of unknown etiology”. It is a macular injury with no known cause. Presentation of the condition differs slightly from one patient to another, but symptoms include any or all of the following:
· Pigmentary Maculopathy
· Retinal Maculopathy
· Macular Degeneration
· Pattern Dystrophy
· Vision Loss / Vision Impairment
· Visual disturbances
· Blurred Vision
· Blindness (unilateral or bilateral)
If you or someone you know have taken the drug Elmiron and experienced any of the above symptoms, contact the Clark Law Firm today.